References
- Arora, D., Chawla, Y., Malakar, B., Singh, A., & Nandicoori, V. K. (2018). The transpeptidase PbpA and noncanonical transglycosylase RodA of Mycobacterium tuberculosis play important roles in regulating bacterial cell lengths. Journal of Biological Chemistry.
- Becker, S. H., Jastrab, J. B., Dhabaria, A., Chaton, C. T., Rush, J. S., & Korotkov, K. V. (2019). The Mycobacterium tuberculosis Pup-proteasome system regulates nitrate metabolism through an essential protein quality control pathway. Proceedings of the National Academy of Sciences of the United States of America, 116(8), 3202–3210.
- Burns, K. E., Liu, W. T., Boshoff, H. I. M., Dorrestein, P. C., & Barry, C. E. (2009). Proteasomal protein degradation in mycobacteria is dependent upon a prokaryotic ubiquitin-like protein. The Journal of Biological Chemistry, 284(5), 3069–3075. https://doi.org/https://doi.org/10.1074/jbc.M808032200
- Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology, 243-250.
- Darwin, K. H., Ehrt, S., Gutierrez-Ramos, J.-C., Weich, N., & Nathan, C. F. (2003). The Proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science (New York, N.Y.).), 302(5652), 1963–1966. https://doi.org/https://doi.org/10.1126/science.1091176
- Festa, R. A., Pearce, M. J., & Darwin, K. H. (2007). Characterization of the proteasome accessory factor (paf) operon in Mycobacterium tuberculosis. Journal of Bacteriology, 189(8), 3044–3050. https://doi.org/https://doi.org/10.1128/JB.01597-06
- Gandotra, S., Lebron, M. B., & Ehrt, S. (2010). The Mycobacterium tuberculosis proteasome active site threonine is essential for persistence yet dispensable for replication and resistance to nitric oxide. PLoS Pathogens, 6(8), e1001040. https://doi.org/https://doi.org/10.1371/journal.ppat.1001040
- Gandotra, S., Schnappinger, D., Monteleone, M., Hillen, W., & Ehrt, S. (2007). In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice. Nature Medicine, 13(12), 1515–1520. https://doi.org/https://doi.org/10.1038/nm1683
- Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997). Structure of 20S proteasome from yeast at 2.4 A resolution. Nature, 386(6624), 463–471. https://doi.org/https://doi.org/10.1038/386463a0
- Harshbarger, W., Miller, C., Diedrich, C., & Sacchettini, J. (2015). Crystal structure of the human 20S proteasome in complex with carfilzomib. Structure (London, England: 1993), 23(2), 418–424. https://doi.org/https://doi.org/10.1016/j.str.2014.11.017
- Hsu, H.-C., Singh, P. K., Fan, H., Wang, R., Sukenick, G., Nathan, C., Lin, G., & Li, H. (2017). Structural basis for the species-selective binding of N,C-capped dipeptides to the Mycobacterium tuberculosis proteasome . Biochemistry, 56(1), 324–333. https://doi.org/https://doi.org/10.1021/acs.biochem.6b01107
- Hu, G., Lin, G., Wang, M., Dick, L., Xu, R.-M., Nathan, C., & Li, H. (2006). Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate. Molecular Microbiology, 59(5), 1417–1428. https://doi.org/https://doi.org/10.1111/j.1365-2958.2005.05036.x
- Jiang, H.-W., Czajkowsky, D. M., Wang, T., Wang, X.-D., Wang, J-b., Zhang, H.-N., Liu, C.-X., Wu, F.-L., He, X., Xu, Z.-W., Chen, H., Guo, S.-J., Li, Y., Bi, L.-J., Deng, J.-Y., Xie, J., Pei, J.-F., Zhang, X.-E., & Tao, S.-C. (2018). Identification of Serine 119 as an effective inhibitor binding site of m. tuberculosis ubiquitin-like protein ligase PafA using purified proteins and M. smegmatis. EBioMedicine, 30, 225–236. https://doi.org/https://doi.org/10.1016/j.ebiom.2018.03.025
- Koodathingal, P., Jaffe, N. E., Kraut, D. A., Prakash, S., Fishbain, S., Herman, C., & Matouschek, A. (2009). ATP-dependent proteases differ substantially in their ability to unfold globular proteins. The Journal of Biological Chemistry, 284(28), 18674–18684. https://doi.org/https://doi.org/10.1074/jbc.M900783200
- Kumar, S., Sharma, P. P., Shankar, U., Kumar, D. (2020). Discovery of new hydroxyethylamine analogs against 3CLpro protein target of SARS-CoV-2: Molecular docking, molecular dynamics simulation, and structure–activity relationship studies. https://doi.org/https://doi.org/10.1021/acs.jcim.0c00326
- Kwon, Y., Do, Nagy, I., Adams, P. D., Baumeister, W., & Jap, B. K. (2004). Crystal structures of the Rhodococcus proteasome with and without its pro-peptides: Implications for the role of the pro-peptide in proteasome assembly. Journal of Molecular Biology, 335(1), 233–245. https://doi.org/https://doi.org/10.1016/j.jmb.2003.08.029
- Lee, C., Schwartz, M. P., Prakash, S., Iwakura, M., & Matouschek, A. (2001). ATP-dependent proteases degrade their substrates by processively unraveling them from the degradation signal. Molecular Cell, 7(3), 627–637. https://doi.org/https://doi.org/10.1016/S1097-2765(01)00209-X
- Lin, G., Hu, G., Tsu, C., Kunes, Y. Z., Li, H., Dick, L., Parsons, T., Li, P., Chen, Z., Zwickl, P., Weich, N., & Nathan, C. (2006). Mycobacterium tuberculosis prcBA genes encode a gated proteasome with broad oligopeptide specificity. Molecular Microbiology, 59(5), 1405–1416. https://doi.org/https://doi.org/10.1111/j.1365-2958.2005.05035.x
- Lowe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W., & Huber, R. (1995). Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science (New York, N.Y.).), 268(5210), 533–539. https://doi.org/https://doi.org/10.1126/science.7725097
- Lupoli, T. J., Vaubourgeix, J., Burns-Huang, K., & Gold, B. (2018). Targeting the proteostasis network for mycobacterial drug discovery. ACS Infect Dis [Internet], acsinfecdis.7b00231. Available from: http://pubs.acs.org/doi/10.1021/acsinfecdis.7b00231
- Migliori, G. B., Loddenkemper, R., Blasi, F., & Raviglione, M. C. (2007). 125 years after Robert Koch's discovery of the tubercle bacillus: The new XDR-TB threat. Is “science” enough to tackle the epidemic? The European Respiratory Journal, 29(3), 423–427. https://doi.org/https://doi.org/10.1183/09031936.00001307
- Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/https://doi.org/10.1002/jcc.21256
- Müller, A. U., & Weber-Ban, E. (2019). The bacterial proteasome at the core of diverse degradation pathways. Frontiers in Molecular Biosciences, 6(23), 1–7. https://doi.org/https://doi.org/10.3389/fmolb.2019.00023
- Nathan, C., Larchmont, N. (U S 514/370, Gang Lin, Forest Hills N (US). 2017. Proteasome inhibitors used in pathogen infection and cancer.
- Nussbaum, A. K., Dick, T. P., Keilholz, W., Schirle, M., Stevanović, S., Dietz, K., Heinemeyer, W., Groll, M., Wolf, D. H., Huber, R., Rammensee, H. G., & Schild, H. (1998). Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1. Proceedings of the National Academy of Sciences of the United States of America, 95(21), 12504–12509. https://doi.org/https://doi.org/10.1073/pnas.95.21.12504
- Pearce, M. J., Mintseris, J., Ferreyra, J., Gygi, S. P., & Darwin, K. H. (2008). Ubiquitin-like protein involved in the proteasome pathway of Mycobacterium tuberculosis. Science (New York, N.Y.).), 322(5904), 1104–1107. https://doi.org/https://doi.org/10.1126/science.1163885
- Prasad, R., & Srivastava, D. K. (2013). Multi drug and extensively drug-resistant TB (M/XDR-TB) management: Current issues. Clinical Epidemiology and Global Health, 1(3), 124–128. https://doi.org/https://doi.org/10.1016/j.cegh.2013.02.003
- Report GT. Global Tuberculosis Report (2016). 2016 World Health Organization. http://Apps.Who.Int/Iris/Bitstream/10665/91355/1/9789241564656_Eng.Pdf.
- Rumende, C. M. (2018). Risk Factors for Multidrug-resistant Tuberculosis. Acta Medica Indonesiana, 50(1), 1–2.
- Russell, D. G. (2011). Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunological Reviews, 240(1), 252–268. https://doi.org/https://doi.org/10.1111/j.1600-065X.2010.00984.x
- Seemüller, E., Lupas, a., Stock, D., Löwe, J., Huber, R., & Baumeister, W. (1995). Proteasome from Thermoplasma acidophilum: A threonine protease. Science (New York, N.Y.).), 268(5210), 579–582. https://doi.org/https://doi.org/10.1126/science.7725107
- Srivastava, M., Suri, C., Singh, M., Mathur, R., & Asthana, S. (2018). Molecular dynamics simulation reveals the possible druggable hotspots of USP7. Oncotarget, 9(76), 34289–34305. https://doi.org/https://doi.org/10.18632/oncotarget.26136
- Suri, C., Hendrickson, T. W., Joshi, H. C., & Naik, P. K. (2014). Molecular insight into γ-γ tubulin lateral interactions within the γ-tubulin ring complex (γ-TuRC). Journal of Computer-Aided Molecular Design, 28(9), 961–972. https://doi.org/https://doi.org/10.1007/s10822-014-9779-2
- Tamura, T., Nagy, I., Lupas, A., Lottspeich, F., Cejka, Z., Schoofs, G., Tanaka, K., De Mot, R., & Baumeister, W. (1995). The first characterization of a eubacterial proteasome: The 20S complex of Rhodococcus. Current Biology, 5(7), 766–774. https://doi.org/https://doi.org/10.1016/S0960-9822(95)00153-9
- Trott, O., & Olson, A. J. (2010). Software news and update AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461.
- Velayati, A. A., Masjedi, M. R., Farnia, P., Tabarsi, P., Ghanavi, J., ZiaZarifi, A. H., & Hoffner, S. E. (2009). Emergence of new forms of totally drug-resistant tuberculosis bacilli: Super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest, 136(2), 420–425. https://doi.org/https://doi.org/10.1378/chest.08-2427
- World Health Organization. (2018). Global TUBERCULOSIS Report 2018 – executive summary. World Health Organization.
- Zheng, Y., Jiang, X., Gao, F., Song, J., Sun, J., Wang, L., Sun, X., Lu, Z., & Zhang, H. (2014). Identification of plant-derived natural products as potential inhibitors of the Mycobacterium tuberculosis proteasome. BMC Complementary and Alternative Medicine, 14, 400 https://doi.org/https://doi.org/10.1186/1472-6882-14-400